ProfileGDS4718 / 228198_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 45% 66% 38% 43% 45% 50% 44% 43% 42% 43% 49% 50% 35% 47% 44% 43% 49% 59% 60% 42% 43% 44% 42% 43% 50% 40% 45% 46% 54% 51% 40% 41% 37% 45% 50% 53% 42% 48% 65% 44% 49% 49% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1899644
GSM549102patient 115, normal, homogenized [OPG study]5.2915745
GSM549104patient 119, normal, homogenized [OPG study]6.5680366
GSM549108patient 138, normal, homogenized [OPG study]4.9585338
GSM549119patient 077, normal, homogenized [OPG study]5.1289743
GSM549133patient 032, cancer, homogenized [OPG study]5.1916845
GSM549139patient 042, cancer, homogenized [OPG study]5.5004150
GSM549099patient 107, normal, homogenized [OPG study]5.2308144
GSM549109patient 139, normal, homogenized [OPG study]5.1853943
GSM549110patient 046, normal, homogenized [OPG study]5.0947542
GSM549114patient 063, normal, homogenized [OPG study]5.0813543
GSM549122patient 082, normal, homogenized [OPG study]5.4378449
GSM549134patient 033, cancer, homogenized [OPG study]5.5106550
GSM549136patient 036, cancer, homogenized [OPG study]4.7138935
GSM549140patient 044, cancer, homogenized [OPG study]5.331847
GSM549111patient 047, normal, homogenized [OPG study]5.175744
GSM549113patient 057, normal, homogenized [OPG study]5.1019743
GSM549132patient 031, cancer, homogenized [OPG study]5.4735549
GSM549137patient 038, cancer, homogenized [OPG study]6.05359
GSM549142patient 047, cancer, homogenized [OPG study]6.2077260
GSM549100patient 110, normal, homogenized [OPG study]5.1218342
GSM549107patient 135, normal, homogenized [OPG study]5.102343
GSM549115patient 068, normal, homogenized [OPG study]5.1164144
GSM549116patient 072, normal, homogenized [OPG study]5.0567142
GSM549120patient 078, normal, homogenized [OPG study]5.1350743
GSM549131patient 030, cancer, homogenized [OPG study]5.4533450
GSM549118patient 074, normal, homogenized [OPG study]5.0001840
GSM549129patient 027, cancer, homogenized [OPG study]5.2420445
GSM549123patient 088, normal, homogenized [OPG study]5.3005546
GSM549124patient 006, cancer, homogenized [OPG study]5.7402354
GSM549126patient 015, cancer, homogenized [OPG study]5.5496451
GSM549128patient 025, cancer, homogenized [OPG study]4.9918440
GSM549103patient 117, normal, homogenized [OPG study]5.1141441
GSM549117patient 073, normal, homogenized [OPG study]4.8287637
GSM549138patient 041, cancer, homogenized [OPG study]5.209145
GSM549141patient 045, cancer, homogenized [OPG study]5.4753350
GSM549130patient 028, cancer, homogenized [OPG study]5.6764253
GSM549101patient 111, normal, homogenized [OPG study]5.1249842
GSM549105patient 128, normal, homogenized [OPG study]5.3956448
GSM549106patient 134, normal, homogenized [OPG study]6.5013465
GSM549112patient 048, normal, homogenized [OPG study]5.186944
GSM549125patient 011, cancer, homogenized [OPG study]5.4857849
GSM549127patient 024, cancer, homogenized [OPG study]5.4727149
GSM549135patient 035, cancer, homogenized [OPG study]5.8979157